Product Name :
(3S, 5S)-Atorvastatin
Description:
(3S,5S)-Atorvastatin is a inactive enantiomer of Atorvastatin. (3S,5S)-Atorvastatin can activate pregnane X receptor (PXR). Atorvastatin is an orally active HMG-CoA reductase inhibitor, has the ability to effectively decrease blood lipids.
CAS:
501121-34-2
Molecular Weight:
558.64
Formula:
C33H35FN2O5
Chemical Name:
(3S, 5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3, 5-dihydroxyheptanoic acid
Smiles :
CC(C)C1=C(C(=C(C2C=CC(F)=CC=2)N1CC[C@H](O)C[C@H](O)CC(O)=O)C1C=CC=CC=1)C(=O)NC1C=CC=CC=1
InChiKey:
XUKUURHRXDUEBC-SVBPBHIXSA-N
InChi :
InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m0/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.{{Artesunate} site|{Artesunate} STAT|{Artesunate} Technical Information|{Artesunate} In stock|{Artesunate} manufacturer|{Artesunate} Autophagy}
Additional information:
(3S,5S)-Atorvastatin is a inactive enantiomer of Atorvastatin. (3S,5S)-Atorvastatin can activate pregnane X receptor (PXR). Atorvastatin is an orally active HMG-CoA reductase inhibitor, has the ability to effectively decrease blood lipids.|Product information|CAS Number: 501121-34-2|Molecular Weight: 558.64|Formula: C33H35FN2O5|Chemical Name: (3S, 5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3, 5-dihydroxyheptanoic acid|Smiles: CC(C)C1=C(C(=C(C2C=CC(F)=CC=2)N1CC[C@H](O)C[C@H](O)CC(O)=O)C1C=CC=CC=1)C(=O)NC1C=CC=CC=1|InChiKey: XUKUURHRXDUEBC-SVBPBHIXSA-N|InChi: InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m0/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 125 mg/mL (223.{{Cediranib} medchemexpress|{Cediranib} Protein Tyrosine Kinase/RTK|{Cediranib} Protocol|{Cediranib} Data Sheet|{Cediranib} custom synthesis|{Cediranib} Cancer} 76 mM; Need ultrasonic).PMID:23546012 |Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Atorvastatin and its inactive enantiomer (3S,5S)-Atorvastatin increases CYP2B and CYP3A mRNA content with equal ability. (3S,5S)-Atorvastatin in 100 μM concentrations induces luciferase activity with an EC50 of 12.4 μM. Addition of (3S,5S)-Atorvastatin to the 2-formylphenylboronic acid (FPBA)/l-tryptophanol mixture induces an intensity enhancement of l-tryptophanol florescence.|Products are for research use only. Not for human use.|